BioSpace News Archive

Nikon Instruments Inc. announced the Nikon Spatial Array Confocal detector for AX systems.

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that the first patient has been dosed in the United States in its Phase 1/2 clinical trial evaluating AU-007 for the treatment of solid tumors.

Veracyte, Inc. (Nasdaq: VCYT) today announced that six abstracts highlighting new data focused on the company’s Decipher urologic cancer testing offerings will be presented at the 2023 ASCO Genitourinary (GU) Cancers Symposium, taking place in San Francisco, Calif. and online, February 16-18, 2023.

Recently, the California Institute of Regenerative Medicine (CIRM) awarded Greenstone Bio $675,000 to find novel treatments for Duchenne Muscular Dystrophy (DMD), a fatal genetic disease with no current cure.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will participate in the following investor conferences in February.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and full year of 2022 after the market close on Wednesday, March 1st, 2023.

BioSyent Inc. is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on March 15, 2023, to shareholders of record at the close of business on February 28, 2023.

Tenax Therapeutics, Inc. (Nasdaq: TENX) announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application with claims covering the use of IV levosimendan in the treatment of pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).

Mirati Therapeutics, Inc., a targeted oncology company, will participate in two upcoming healthcare conferences.

ImmunoGen, Inc. announced that the following presentations by Company management at upcoming investor conferences will be webcast.